UK High Court confirms Capital Reduction

RNS Number : 7714P
Caspian Sunrise plc
22 June 2022
 

22 June 2022

 

Caspian Sunrise PLC

UK High Court confirms Capital Reduction

 

Introduction

The Board of Caspian Sunrise PLC ("Caspian Sunrise" or the "Company") is pleased to report the UK High Court yesterday confirmed the Capital Reduction approved by Caspian Sunrise shareholders on 22 April 2022.

 

Accordingly, the Company will now cancel its share premium and deferred shares, which will create positive distributable reserves and remove the last technical block to the future declaration of dividends.

 

Caspian Sunrise PLC

 

Clive Carver

Executive Chairman  +7 727 375 0202

 

WH Ireland, Nominated Adviser & Broker

 

James Joyce  +44 (0) 207 220 1666

Andrew de Andrade

 

This announcement has been posted to:

www.caspiansunrise.com/investors

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXKAADFAEEA
UK 100

Latest directors dealings